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P ostoperative pain control is important for patients who have undergone a total hip arthroplasty 
(THA).  Poor postoperative pain control increases the 
risk of postoperative comorbidities,  delaying physical 
therapy and prolonging hospitalization [1-4].  Moreover,  
poor control of acute postoperative pain can lead to the 
development of chronic pain [1].  The American Society 
of Anesthesiologists (ASA) recommends the multi-
modal control of postoperative pain,  and the ASA pre-
sented guidelines on the management of postoperative 
pain [5].  Various analgesics such as non-steroidal anti- 
inflammatory drugs (NSAIDs),  opioids,  local anesthe-
sia,  and acetaminophen are useful for multimodal anal-
gesia,  and they can reduce the amount of analgesics 
used as well as the risk of adverse events.  This allows 
physicians to implement safe,  high-quality pain man-
agement to patients in the perioperative period [6-8].  
However,  NSAIDs increase the incidence of digestive 
symptoms,  and opioids are associated with adverse 
effects such as nausea and vomiting,  pruritus,  anuresis,  
massive sedation,  respiratory failure,  and ileus [9 , 10].
Acetaminophen is used for patients (from children 
to the elderly) who have symptoms of pain or fever.  
Oral and suppository versions of acetaminophen are 
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We evaluated the analgesic effects of multimodal pain control in which intravenous acetaminophen (IV APAP) 
was added to the standard protocol for Japanese patients who had undergone a total hip arthroplasty (THA).  
We performed a retrospective cohort study of 180 patients aged 66.4 ± 10.5 years (30% male) who had under-
gone a THA (Oct. 2014 to Feb. 2015) at our hospital.  The control patients were administered the standard anal-
gesic protocol: flurbiprofen axetil as a continuous intravenous infusion and oral celecoxib (NAPAP; n = 109).  
The patients in the new analgesic protocol group received IV APAP in addition to the standard analgesic proto-
col (APAP; n = 71).  The primary outcome was the maximum value of postoperative pain the patients reported 
on a numerical rating scale (NRS) during the first 24 h post-surgery.  A univariate analysis and multivariate 
analyses adjusted for age,  sex,  the stage of hip osteoarthritis,  preoperative pain,  and surgical time showed that 
the maximum postoperative pain NRS scores during the first 24 h after surgery was significantly lower when the 
APAP protocol was used.  The addition of IV APAP to the current standard multimodal analgesia protocol for 
Japanese patients who have undergone a THA may decrease the patients’ postoperative pain.
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commercially available in Japan.  With differing levels of 
pain or fever,  patients may have difficulty using such 
oral or suppository agents,  and intravenous acetamino-
phen (IV APAP) offers a new option for such patients;  
it is considered a helpful agent for pain management.  
IV APAP has been commercially available since 2002 in 
the U.S.,  and has been introduced in 80 countries 
worldwide.  The Japanese Ministry of Health,  Labor,  
and Welfare approved IV APAP as a commercial agent 
in 2013.
The administration of IV APAP in the perioperative 
period of orthopedic surgery,  including THA,  decreases 
the patient’s postoperative pain,  length of stay,  and 
hospitalization costs,  as it reaches higher blood levels 
more rapidly compared to other formulations [3 , 4 , 11-
16].  The use of IV APAP also reduces the amount of 
opioids and other rescue agents used [17-20].  However,  
most of these previous studies were of Western patient 
populations,  and no studies have evaluated the post- 
operative effects of IV APAP in Japanese patients.  We 
conducted the present study to compare the effects of 
postoperative analgesia and the risk of adverse events in 
the postoperative period for Japanese patients receiving 
multimodal pain control with and without IV APAP.  
We also investigated whether the analgesic effect of IV 
APAP was dependent on the severity of hip osteoar-
thritis (OA).
Patients and Methods
Study design and settings. This study was con-
ducted in accord with the Declaration of Helsinki and 
approved by the Ethics Committee of our hospital 
(approval no. 2015-04-15).  Formal patient consent was 
not required for this retrospective study.
We performed a retrospective cohort study to evalu-
ate that IV APAP in addition to the standard analgesic 
protocol would be more effective than the standard 
analgesic protocol.  Patients who had undergone a THA 
on one side during the period from October 2014 to 
February 2015 at Saga University Hospital were 
included in this study.  We excluded the cases of the 
patients who had any pain in any other part of the body,  
hepatic or renal disorders,  psychiatric disorders,  or 
drug dependence; patients who had taken an NSAID in 
the 12 h before surgery,  or were administered any anal-
gesic agent during the operation or had a severe con-
sciousness disturbance during the postoperative period.
THA and postoperative analgesic protocols. All 
patients were prescribed rilmazafone hydrochloride 
hydrate (Rhythmy®; Kyowa Pharmaceutical,  Osaka,  
Japan) 2 mg as premedication at bedtime on the day 
prior to surgery,  and all received lactate Ringer’s solu-
tion (Lactec® Injection; Otsuka Pharmaceutical,  Tokyo) 
intravenously when entering the operating room.  Each 
THA was performed under spinal anesthesia.  The spi-
nal anesthesia was induced using a standard technique:  
0.5% isobaric bupivacaine was administered in a single 
shot using a 27-G pencil-type spinal needle at the L3-L4 
vertebral level.  Some patients were received midazolam 
(2-3 mg IV) for conscious sedation.  All patients received 
multimodal analgesia after the completion of surgery.
Our hospital officially adopted the use of IV APAP in 
November 2014.  In January 2015,  we implemented a 
new pain management protocol in which IV APAP was 
added to the existing pain management protocol.  
Patients who had undergone a THA during the period 
from October to December 2014 were administered 
flurbiprofen axetil (Ropion®; Kaken Seiyaku,  Tokyo) 
50 mg as a continuous intravenous infusion and cele-
coxib (Celecox®; Astellas Pharma,  Tokyo) 400 mg per 
day orally,  as the standard analgesic protocol.  We 
defined these patients as the control group (NAPAP 
group).
The patients who comprised the new analgesic pro-
tocol group (i.e.,  the APAP group who underwent a 
THA in January-February 2015) received IV APAP 
(Acelio® Intravenous Injection; Terumo,  Tokyo) at 
1,000 mg for patients with body weights ≥ 50 kg and 
15 mg/dl for patients with body weights < 50 kg as an 
intravenous infusion every 6 h within the first 24 h after 
surgery,  in addition to the existing analgesic protocol.
When a patient in either the NAPAP or APAP group 
required one or more additional analgesic agents for 
postoperative pain,  he or she was administered 
diclofenac sodium (Voltaren® SUPPO®; Novartis 
Pharma,  Tokyo) 50 mg,  or acetaminophen (Calonal® 
Tablet; Ayumi Pharmaceutical,  Tokyo) 200 mg rec-
tally,  or pentazocine (Sosegon® Injection; Maruishi 
Pharmaceutical,  Tokyo) 15 mg intravenously as rescue 
drugs.
Data collection and outcomes. We reviewed the 
patients’ electronic medical charts to obtain data 
including the patient’s age,  sex,  and body mass index 
(BMI) at the time of surgery.  Laboratory and imaging 
test data such as the complete blood count,  differential 
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leukocyte count,  liver and renal function parameters,  
and X-ray findings of the hip joint were also collected.  
The severity of OA was graded using the Japanese 
Orthopedic Association criteria as follows: stage 1 
(pre-OA stage),  no osteoarthritic change; stage 2 (ini-
tial stage),  slight narrowing of the joint space associated 
with sclerosis of the subchondral bone; stage 3 
(advanced stage),  narrowing of the joint space with 
cystic radiolucencies and small osteophytes; and stage 
4 (end stage),  almost no joint space and marked osteo-
phyte formation [21 , 22].  The surgical time,  anesthesia 
procedure,  anesthetic agents,  and analgesic agents 
administered during the operation were recorded.
Each patient’s postoperative consciousness level was 
measured using the Japan Coma Scale [23] immediately 
after surgery.  The intensity of each patient’s postopera-
tive pain was measured with the use of a self-reported 
numerical rating scale (NRS); this was an 11-level scale 
with 0 = no pain,  to 10 = worst pain imaginable [24].  
The postoperative pain NRS score was measured by 
nurses at 0 , 1 , 6,  and 24 h after surgery while the patient 
was at rest,  and the scores were recorded on the 
patient’s electronic medical chart.  The postoperative 
pain NRS score at the time when a patient used rescue 
analgesic drugs was also recorded,  as were the names 
and amounts of such drugs required,  in the electronic 
medical charts.  Lumbar pain NRS scores were deter-
mined in a similar manner.  When the patient asked for 
a rescue analgesic due to postoperative pain,  the 
patient’s physician selected the type and amount of the 
rescue analgesic (e.g.,  diclofenac sodium 50 mg) and 
administered it.
The primary outcome of this study was the maxi-
mum postoperative pain NRS score during the first 24 h 
post-surgery,  In our research protocol,  we planned to 
use the pain NRS scores measured at 0 , 1 , 6, 24 h after 
surgery and at the time that patients requested rescue 
analgesic drugs for their postoperative pain for our 
analysis.  However,  the pain NRS scores at those time 
points were often missing from the medical chart review 
and could not be used for analysis.  We therefore used 
the maximum postoperative pain NRS score within 24 h 
after surgery from the medical chart review as the pri-
mary endpoint for our analysis.
Secondary outcomes were the maximum lumbar 
pain NRS score,  the frequency of nurse calls,  and the 
administration of analgesic rescue agents.  The inci-
dence of postoperative nausea or vomiting (PONV) was 
recorded as an adverse event.  We defined PONV as 
postoperative nausea or vomiting during the first 24 h 
post-surgery.
Statistical analysis. We evaluated the character-
istics of the NAPAP and APAP groups before surgery:  
age,  sex,  hip joint and lumbar pain NRS scores,  anal-
gesic medication,  hip joint x-ray findings,  diagnoses of 
hip pain,  laboratory data,  surgical time,  and total 
amount of perioperative bleeding.  We compared these 
parameters between the groups using the chi-square test 
or Fisher’s exact test for categorical variables.  For con-
tinuous variables,  we used Student’s t-test or the Mann-
Whitney U-test to analyze numerical data.  We also used 
the Mann-Whitney U-test to compare the maximum 
postoperative and lumbar pain NRS scores in the first 
24 h after surgery,  the frequency of nurse calls,  and the 
use of rescue drugs.  We performed a logistic regression 
analysis to calculate the odds ratio of the incidence of 
PONV.  Multiple linear regression analyses were con-
ducted to examine the differences in outcomes,  the 
maximum postoperative pain NRS score,  the postoper-
ative lumbar pain NRS score,  the frequency of using 
rescue drug and nurse calls between the APAP and 
NAPAP groups,  with the patient’s sex,  age,  severity of 
hip OA,  and surgical time as other explanatory vari-
ables [25 , 26].  We also performed sub-group analyses 
that were based on the severity of hip OA prior to sur-
gery.  We defined patients with pre-OA,  initial OA or 
the advanced stage of OA as the mild-stage OA group,  
and the patients with end-stage OA as the severe-stage 
OA group.  All statistical analyses were performed using 
Stata MP for Macintosh,  ver. 13 (Stata,  College Station,  
TX,  USA).
Results
Our patient series was 180 Japanese THA patients 
(APAP: n = 71,  NAPAP: n = 109) with the mean age 
66.4 ± 10.5 years; 30% of the patients were male.  There 
were no significant between-group difference in pre- 
operative patient characteristics,  including age,  sex,  
hip joint pain NRS score,  lumbar pain NRS score,  the 
use of analgesic agents,  type of analgesic medication,  
hip OA x-ray findings,  diagnoses,  and laboratory data.  
The surgical time and the total amount of bleeding were 
also not significantly different between the APAP and 
NAPAP groups (Table 1).
The univariate analysis revealed that the maximum 
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postoperative pain NRS score during the first 24 h 
post-surgery was significantly lower in the APAP patients 
compared to the NAPAP patients (APAP: 4.2 ± 3.0,  
NAPAP: 5.1 ± 2.9,  p = 0.032).  The maximum lumbar 
pain NRS score and the frequency of nurse calls were 
not significantly different between the groups.  The fre-
quency of the use of rescue drugs was also significantly 
lower in the APAP group (APAP: 1.0 ± 0.9,  NAPAP:  
1.4 ± 1.2,  p = 0.026; Table 2).
The multivariate analyses adjusted for age,  sex,  the 
severity of OA of the hip,  and the surgical time showed 
that the maximum postoperative pain NRS score during 
the first 24 h post-surgery was significantly lower with 
the use of the APAP protocol compared to the use of 
NAPAP (beta coefficient [β]: −0.93,  95% confidence 
interval [CI]: −1.79 to −0.08,  p=0.033).  The frequency 
of using rescue drugs in the APAP group remained sig-
nificantly lower than that in the NAPAP group 
(β: −0.34,  95%CI: −0.65 to −0.03,  p = 0.032).  The 
maximum lumbar pain NRS score (β: 0.43,  p = 0.334) 
and the frequency of nurse calls (β: 0.39,  p = 0.244) 
were not significantly different between the groups.  The 
risk of PONV in the APAP group was lower than that in 
the NAPAP group but not significantly so (adjusted odds 
ratio: 0.80,  95%CI: 0.22 to 2.95,  p = 0.739) (Table 3).
The subgroup analysis based on the severity of the 
patients’ hip OA revealed that the postoperative and 
lumbar pain NRS scores were not significantly different 
among the patients with mild hip OA but were lower in 
the APAP group among the patients with severe hip OA 
(Table 4).
10 Fukumori et al. Acta Med.  Okayama　Vol.  73,  No.  1
Table 1　 The preoperative characteristics of all patients
Overall
(N＝180)
APAP
(N=71)
NAPAP
(N=109) P value
Age,  mean ± SD 66.4±10.5 66.5±9.7 66.4±11.1 0.873
Sex (Male),  no.  (%) 30 (16.7) 12 (16.9) 18 (16.5) 0.946
Hip pain NRS,  mean ± SD 5.5±2.6 5.7±2.8 5.4±2.4 0.372
Lumbar pain NRS,  mean ± SD 2.4±2.4 2.5±2.3 2.4±2.4 0.597
Diagnoses of OA,  no.  (%) 0.335
　Developmental dysplasia of hip 172 (95.6) 68 (95.8) 104 (95.4)
　Idiopathic osteonecrosis of femoral head 3 (1.7) 2 (2.8) 1 (0.9)
　Rheumatoid arthritis 2 (1.1) 1 (1.4) 1 (0.9)
　others 3 (1.7) 0 (0.0) 3 (2.8)
Severity of OA hip,  no.  (%) 0.322
　Initial stage 2 (1.1) 1 (1.4) 1 (0.9)
　Advanced stage 26 (14.4) 7 (9.9) 19 (17.4)
　End stage 149 (82.8) 63 (88.7) 86 (78.9)
Analgesic agents,  no.  (%)
　Acetaminophen 4 (2.2) 0/71 (0.0) 4/109 (3.7) 0.155 
　Diclofenac sodium 6 (3.3) 1/71 (1.4) 5/109 (4.6) 0.405
　COX-2 inhibitor 57 (31.7) 27/71 (38.0) 30/109 (27.5) 0.139
　Pregabalin 5 (2.8) 4/71 (5.6) 1/109 (0.9) 0.080
　Benzodiazepine 1 (0.6) 0/71 (0.0) 1/109 (0.9) 1.000
　other 14 (7.8) 7/71 (9.9) 7/109 (6.4) 0.400
Laboratory data,  mean ± SD
　WBC (×103/µl) 6.2±1.9 6.2±1.8 6.2±1.8 0.613
　Hemoglobin (g/dl) 13.1±1.4 13.1±1.4 13.1±1.4 0.976
　AST (IU/l) 22.3±6.6 22.3±7.0 22.3±6.5 0.876
　ALT (IU/l) 17.7±9.4 18.6±9.0 17.2±9.7 0.162
　Creatinine (mg/dl) 0.75±0.70 0.63±0.18 0.83±0.88 0.056
Surgical time (min),  mean ± SD 46.5±12.9 47.4±13.5 45.9±12.6 0.361
Total bleeding (ml),  mean ± SD 482.0±174.8 482.0±165.9 481.9±181.2 0.946
APAP,  administration of intravenous acetaminophen; NAPAP,  no administration of intravenous acetaminophen; SD,  standard devia-
tion; NRS,  numerical rating scale; OA,  osteoarthritis; WBC,  white blood cell; AST,  aspartate transaminase; ALT,  alanine aminotrans-
ferase.
Discussion
We investigated whether the intensity of postopera-
tive pain could be changed by the addition of IV APAP 
as multimodal analgesia among patients with hip OA 
who had undergone a THA.  The multivariate analyses 
adjusted for age,  sex,  the severity of hip OA,  preoper-
ative pain,  and surgical time showed that the postoper-
ative pain NRS score in the patients who received IV 
APAP in addition to the standard multimodal analgesia 
was lower compared to the scores of the patients who 
did not receive additional APAP.  This result corre-
sponded with those of studies that evaluated the effect of 
IV APAP in Western populations [12 , 13 , 18 , 27],  sug-
gesting that the analgesic effect of IV APAP in Japanese 
patients is similar to that in Western patients.
The frequency of rescue drug use during the first 
24 h post-surgery was lower in the APAP group than in 
the NAPAP group.  Singla et al.  reported that adminis-
tering IV APAP after a THA decreased the dosage of 
rescue drugs required to less than half of that required 
when a placebo was administered [17].  An intravenous 
infusion produces a rapid elevation in the plasma con-
centration of acetaminophen and obtains a stable anal-
gesic effect compared with that obtained by oral or rec-
tal administration [11].  For the present study’s patients,  
IV APAP was administered every 6 h within the first 
24 h post-surgery,  in addition to the standard analgesic 
protocol; the analgesic effect achieved by this approach 
was stable in the early post-surgical phase and the fre-
quency of using rescue drugs was decreased.
On the other hand,  the lumbar pain NRS score and 
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Table 2　 Comparison of postoperative outcomes between the APAP and NAPAP groups: Univariate analysis
APAP (N＝71) NAPAP (N＝109) P value
Postoperative pain NRS,  mean ± SD 4.2±3.0 5.1±2.9 0.032
Lumbar pain NRS,  mean ± SD 5.0±2.9 4.4±3.0 0.234
Frequency of rescue drugs,  mean ± SD 1.0±0.9 1.4±1.2 0.026
Rescue drugs,  no.  (%)
　Acetaminophen 6 (8.5) 7 (6.4) 0.769
　Diclofenac sodium 39 (54.9) 66 (60.6) 0.536
　COX-2 inhibitor 1 (1.4) 1 (0.9) 1.000
　Pregabalin 0 (0.0) 3 (2.8) 0.279
　Opioids 6 (8.5) 25 (22.9) 0.015
Frequency of Nurse calls,  mean ± SD 2.3±2.3 1.9±2.0 0.436
PONV,  no.  (%) 4 (5.6) 7 (6.4) 1.000
APAP,  administration of intravenous acetaminophen; NAPAP,  no administration of intravenous acetaminophen; SD,  standard devia-
tion; NRS,  numerical rating scale; PONV,  postoperative nausea and vomiting.
Table 3　 The analgesic eﬀect of adding IV APAP,  based on the multivariate analysis
βa 95% CI P value
Primary outcome
　Postoperative pain NRS －0.93 －1.79 －0.08 0.033 
Secondary outcome
　Postoperative lumbar pain NRS 0.43 －0.45 1.31 0.334
　Frequency of using rescue drugs －0.34 －0.65 －0.03 0.032
　Frequency of nurse calls 0.39 －0.27 1.06 0.244
AOR＊ 95% CI P value
　PONV 0.80 0.22 2.95 0.739
aMultivariate linear regression analyses adjusted for age,  sex,  severity of osteoarthritis of hip,  preoperative pain of hip,  surgical time
β,  Beta coeﬃcient; CI,  conﬁdence interval; NRS,  numerical rating scale; PONV,  postoperative nausea and vomiting; AOR,  adjusted 
odds ratio.
＊Multivariate logistic regression analyses adjusted for age,  sex,  severity of osteoarthritis of hip,  preoperative pain of hip,  surgical time
the frequency of nurse calls were not decreased in these 
THA patients.  No study to date has evaluated the effect 
of administering IV APAP for lumbar pain on the fre-
quency of postoperative nurse calls.  The postoperative 
lumbar pain of the patients in this study was higher 
than the preoperative lumbar pain.  The risk factors for 
the development of back pain after neuraxial anesthesia 
include the lithotomy position,  multiple attempts at 
block placement,  duration of surgery > 2.5 h,  BMI 
≥ 32 kg/m2,  and a history of back pain [28].  We suspect 
that these risk factors were related to the strength of the 
postoperative lumbar pain in our patient series.
Factors other than the surgical procedure such as 
total bed-time after surgery and the presence or absence 
of osteoporosis may strongly affect the intensity of lum-
bar pain.  With regard to the frequency of nurse calls,  
we did not ascertain the reasons that patients called 
nurses after their surgery,  and it is possible that some of 
the patients called nurses for reasons other than pain.
The prevalence of PONV during the first 24 h 
post-surgery was not significantly different between the 
NAPAP and APAP groups.  Karvonen et al.  reported 
that the incidence of adverse events such as nausea and 
vomiting did not increase after the administration of 
acetaminophen for the patients received with major 
orthopedic surgery [20].  It is commonly believed that 
the incidence of PONV depends on the dose of opioids 
used [9 , 29].  In our study,  the attending physicians 
chose the type of rescue drugs used for postoperative 
pain control; they administered diclofenac sodium 
(50 mg) in almost all cases,  rather than opioids.  This 
may explain the lack of a significant difference in the 
incidence of PONV between the NAPAP and APAP 
groups.  Since the administration of IV APAP in addi-
tion to the standard analgesics decreases the dose of 
opioids required,  it also facilitates the safe control of 
postoperative pain.  On the other hand,  the postopera-
tive pain intensity reported by our patients was higher 
than in previous studies.  This might be related to the 
avoidance of opioids for postoperative pain manage-
ment in our series.  Physicians need to consider both the 
advantages and disadvantages of the use of opioids for 
postoperative pain control [6 , 30].
In our subgroup analysis based on the severity of hip 
OA,  the intensity of postoperative pain as indicated by 
the NRS and the frequency of rescue drugs after surgery 
were both markedly decreased with added IV APAP 
among the patients with severe OA.  In another study,  
patients with mild hip OA had stronger postoperative 
pain and decreased physical activity compared to 
patients with severe hip OA [31].  Thus,  in the present 
study the effect of adding IV APAP might have been 
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Table 4　 Subgroups analysis based on the severity of the patientsʼ hip osteoarthritis
A. Mild stage of OA
Beta coeﬃcienta 95% CI P value
Primary outcome
　Postoperative pain NRS 0.03 －2.84 2.90 0.982
Secondary outcome
　Postoperative lumbar pain NRS －0.63 －3.29 2.04 0.630
　Frequency of using rescue drugs －0.22 －1.10 0.66 0.603
　Frequency of nurse calls －1.29 －3.70 1.13 0.281
B. Severe stage of OA
Beta coeﬃcienta 95% CI P value
Primary outcome
　Postoperative pain NRS －1.12 －2.03 －0.20 0.017
Secondary outcome
　Postoperative lumbar pain NRS 0.58 －0.38 1.54 0.234
　Frequency of using rescue drugs －0.36 －0.71 －0.01 0.041
　Frequency of nurse calls 0.67 －0.03 1.37 0.059
aMultivariate liner regression analyses adjusted for age,  sex,  severity of osteoarthritis of hip,  surgical time
OA,  osteoarthritis; CI,  conﬁdence interval; NRS,  numerical rating scale; PONV,  postoperative nausea and vomiting; AOR,  adjusted 
odds ratio.
greater among the patients with severe hip OA.  It is not 
possible to make this conclusion,  however,  because the 
number of patients with mild hip OA was small.  
Further evaluations of a larger number of patients are 
required to confirm the analgesic effects of IV APAP in 
such patients.
There are some limitations to this study.  First,  we 
may not have adjusted for all possible subclinical con-
founders,  as we performed a retrospective observa-
tional study to evaluate the analgesic effect of IV APAP.  
The intensity of pain has been shown to be modified not 
only by the severity of the primary disease,  but also by 
the psychological state of the patients [32].  It would 
have been ideal to adjust for the mental conditions of 
patients,  such as depression.  The patients in this study 
were enrolled by continuous sampling,  and their 
pre-operative characteristics did not differ significantly 
between the groups; we therefore believe that there 
were no major distinctions between our NAPAP and 
APAP groups.
Secondly,  the NRS score might not be accurate,  as 
the postoperative pain NRS score,  which was the pri-
mary outcome of this study,  was rated by the patients 
themselves,  and this may be less accurate in the case of 
elderly and severely demented patients [24].  The mean 
age of patients of this study (approx.  66 years) was not 
particularly old; we thus believe that the accuracy of the 
NRS score may be acceptable.  In addition,  in our initial 
research protocol,  we had planned to use the postoper-
ative pain NRS scores measured at 0 , 6 , 12 , 24 h after 
surgery for the analysis,  but we could not do so because 
there were many missing values from the medical chart 
review.  Therefore,  we could not refer sufficiently to the 
time course of the intensity of the postoperative pain.
Finally,  it is possible that the study suffered from a 
selection bias.  We performed this study at a single uni-
versity hospital; patients with severe disease may thus 
have been more likely to be enrolled in this study.  The 
analgesic effect of IV APAP for postoperative pain 
should be evaluated in a multicenter study in order to 
test the generalizability of these results.
In conclusion,  the intravenous administration of 
APAP in addition to the standard multimodal analgesia 
for Japanese patients who had undergone a THA may 
decrease the postoperative pain NRS score and the fre-
quency of using rescue drugs during the first 24 h 
post-surgery.  This multimodal analgesia also appears to 
be safe,  as it did not increase the incidence of adverse 
events such as PONV.
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